Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 2
1947 3
1948 3
1949 3
1950 2
1951 2
1952 2
1953 2
1954 3
1955 1
1956 1
1960 3
1962 4
1963 2
1964 4
1965 5
1966 2
1967 5
1968 5
1969 2
1970 3
1971 9
1972 4
1973 9
1974 10
1975 9
1976 5
1977 11
1978 6
1979 7
1980 8
1981 9
1982 8
1983 11
1984 9
1985 10
1986 21
1987 13
1988 14
1989 15
1990 21
1991 20
1992 24
1993 29
1994 19
1995 25
1996 13
1997 19
1998 24
1999 12
2000 15
2001 23
2002 14
2003 19
2004 20
2005 20
2006 13
2007 22
2008 18
2009 22
2010 21
2011 19
2012 25
2013 27
2014 25
2015 24
2016 26
2017 35
2018 22
2019 36
2020 37
2021 36
2022 40
2023 31
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

976 results

Results by year

Filters applied: . Clear all
Page 1
Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference.
Mueller MM, Van Remoortel H, Meybohm P, Aranko K, Aubron C, Burger R, Carson JL, Cichutek K, De Buck E, Devine D, Fergusson D, Folléa G, French C, Frey KP, Gammon R, Levy JH, Murphy MF, Ozier Y, Pavenski K, So-Osman C, Tiberghien P, Volmink J, Waters JH, Wood EM, Seifried E; ICC PBM Frankfurt 2018 Group. Mueller MM, et al. Among authors: burger r. JAMA. 2019 Mar 12;321(10):983-997. doi: 10.1001/jama.2019.0554. JAMA. 2019. PMID: 30860564
Incorporation of bevacizumab in the primary treatment of ovarian cancer.
Burger RA, Brady MF, Bookman MA, Fleming GF, Monk BJ, Huang H, Mannel RS, Homesley HD, Fowler J, Greer BE, Boente M, Birrer MJ, Liang SX; Gynecologic Oncology Group. Burger RA, et al. N Engl J Med. 2011 Dec 29;365(26):2473-83. doi: 10.1056/NEJMoa1104390. N Engl J Med. 2011. PMID: 22204724 Free article. Clinical Trial.
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer.
Tewari KS, Burger RA, Enserro D, Norquist BM, Swisher EM, Brady MF, Bookman MA, Fleming GF, Huang H, Homesley HD, Fowler JM, Greer BE, Boente M, Liang SX, Ye C, Bais C, Randall LM, Chan JK, Ferriss JS, Coleman RL, Aghajanian C, Herzog TJ, DiSaia PJ, Copeland LJ, Mannel RS, Birrer MJ, Monk BJ. Tewari KS, et al. Among authors: burger ra. J Clin Oncol. 2019 Sep 10;37(26):2317-2328. doi: 10.1200/JCO.19.01009. Epub 2019 Jun 19. J Clin Oncol. 2019. PMID: 31216226 Free PMC article. Clinical Trial.
Inherited Mutations in Women With Ovarian Carcinoma.
Norquist BM, Harrell MI, Brady MF, Walsh T, Lee MK, Gulsuner S, Bernards SS, Casadei S, Yi Q, Burger RA, Chan JK, Davidson SA, Mannel RS, DiSilvestro PA, Lankes HA, Ramirez NC, King MC, Swisher EM, Birrer MJ. Norquist BM, et al. Among authors: burger ra. JAMA Oncol. 2016 Apr;2(4):482-90. doi: 10.1001/jamaoncol.2015.5495. JAMA Oncol. 2016. PMID: 26720728 Free PMC article.
Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation Study.
You B, Purdy C, Copeland LJ, Swisher EM, Bookman MA, Fleming G, Coleman R, Randall LM, Tewari KS, Monk BJ, Mannel RS, Walker JL, Cappuccini F, Cohn D, Muzaffar M, Mutch D, Wahner-Hendrickson A, Martin L, Colomban O, Burger RA. You B, et al. Among authors: burger ra. J Clin Oncol. 2022 Dec 1;40(34):3965-3974. doi: 10.1200/JCO.22.01207. Epub 2022 Oct 17. J Clin Oncol. 2022. PMID: 36252167 Free PMC article. Clinical Trial.
Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study.
Zamarin D, Burger RA, Sill MW, Powell DJ Jr, Lankes HA, Feldman MD, Zivanovic O, Gunderson C, Ko E, Mathews C, Sharma S, Hagemann AR, Khleif S, Aghajanian C. Zamarin D, et al. Among authors: burger ra. J Clin Oncol. 2020 Jun 1;38(16):1814-1823. doi: 10.1200/JCO.19.02059. Epub 2020 Apr 10. J Clin Oncol. 2020. PMID: 32275468 Free PMC article. Clinical Trial.
The effects of the "physical BEMER® vascular therapy", a method for the physical stimulation of the vasomotion of precapillary microvessels in case of impaired microcirculation, on sleep, pain and quality of life of patients with different clinical pictures on the basis of three scientifically validated scales.
Bohn W, Hess L, Burger R. Bohn W, et al. Among authors: burger r. J Complement Integr Med. 2013;10(Suppl):S5-12, S5-13. doi: 10.1515/jcim-2013-0037. J Complement Integr Med. 2013. PMID: 23940071 Clinical Trial. English, German.
Editorial: Neuromodulatory Function in Auditory Processing.
Burger RM, Kopp-Scheinpflug C. Burger RM, et al. Front Neural Circuits. 2022 May 17;16:898646. doi: 10.3389/fncir.2022.898646. eCollection 2022. Front Neural Circuits. 2022. PMID: 35664460 Free PMC article. No abstract available.
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.
Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke-Pearson D, Burger RA, Mannel RS, DeGeest K, Hartenbach EM, Baergen R; Gynecologic Oncology Group. Ozols RF, et al. Among authors: burger ra. J Clin Oncol. 2003 Sep 1;21(17):3194-200. doi: 10.1200/JCO.2003.02.153. Epub 2003 Jul 14. J Clin Oncol. 2003. PMID: 12860964 Corrected and republished. Clinical Trial.
Challenges and opportunities in academic neurosurgery.
Burger R, Bolton WS, Mathew RK. Burger R, et al. Br J Hosp Med (Lond). 2021 Oct 2;82(10):1-7. doi: 10.12968/hmed.2021.0297. Epub 2021 Oct 26. Br J Hosp Med (Lond). 2021. PMID: 34726938 Review.
976 results